Dadha Pharma Profile
Key Indicators
- Authorised Capital ₹ 42.50 Cr
- Paid Up Capital ₹ 9.87 M
- Company Age 89 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 73.12 Cr
- Revenue Growth 247.60%
- Profit Growth 357.13%
- Ebitda -626.71%
- Net Worth 28.39%
- Total Assets 20.77%
About Dadha Pharma
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN1935PTC003302
-
Company No.
003302
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Aug 1935
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Dadha Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubda Dadha
|
Director | 18-Jun-2016 | Current |
|
Mohanchand Dadha
|
Whole-Time Director | 31-Jan-1997 | Current |
Financial Performance of Dadha Pharma.
Dadha Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 247.6% increase. The company also saw a substantial improvement in profitability, with a 357.13% increase in profit. The company's net worth Soared by an impressive increase of 28.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dadha Pharma?
Unlock access to Dadha Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Netmeds Healthcare LimitedMohanchand Dadha is a mutual person
-
Keuro Life LlpShubda Dadha and Mohanchand Dadha are mutual person
-
Dadha Pharma Llp
Shubda Dadha and Mohanchand Dadha are mutual person
-
Rhr Health And Technology Llp
Shubda Dadha and Mohanchand Dadha are mutual person
-
Tresara Health Limited
Mohanchand Dadha is a mutual person
-
Dadha Pharma Distribution Limited
Mohanchand Dadha is a mutual person
Charges (Loans)
₹0
₹73.12 Cr
Charges Breakdown by Lending Institutions
- Others : 27.62 Cr
- The Catholic Syrian Bank Ltd : 17.29 Cr
- Axis Bank Limited : 16.42 Cr
- The Catholic Synian Bank : 4.30 Cr
- Catholic Syrian Bank Limited : 4.00 Cr
- Others : 3.49 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2021 | Hdfc Bank Limited | ₹1.03 Cr | Satisfied |
| 22 Oct 2019 | Others | ₹4.95 Cr | Satisfied |
| 13 Sep 2011 | Others | ₹22.67 Cr | Satisfied |
| 11 Jul 2009 | Axis Bank Limited | ₹16.42 Cr | Satisfied |
| 07 Sep 2004 | The Catholic Synian Bank | ₹3.00 M | Satisfied |
How Many Employees Work at Dadha Pharma?
Dadha Pharma has a workforce of 27 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dadha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dadha Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
